Monash Bioethics Review 23 (2):9-20 (2004)

David Neil
University of Wollongong
Of the future technologies arising from the Human Genome Project, pharmacogenomics will probably be the first to have a widespread impact on the everyday practice of medicine. This technology offers great benefits but also presents some difficult ethical challenges. This paper explains what pharmacogenomics is and examines three of the issues that it raises: orphan populations, the use of ethnicity in drug trials, and potential obstacles to informed consent for genetic testing.
Keywords No keywords specified (fix it)
Categories (categorize this paper)
DOI 10.1007/bf03351409
Edit this record
Mark as duplicate
Export citation
Find it on Scholar
Request removal from index
Revision history

Download options

PhilArchive copy

Upload a copy of this paper     Check publisher's policy     Papers currently archived: 68,975
External links

Setup an account with your affiliations in order to access resources via your University's proxy server
Configure custom proxy (use this if your affiliation does not provide a proxy)
Through your library

References found in this work BETA

No references found.

Add more references

Citations of this work BETA

The Changing Legal and Conceptual Shape of Health Care Privacy.Roger S. Magnusson - 2004 - Journal of Law, Medicine and Ethics 32 (4):680-691.
The Changing Legal and Conceptual Shape of Health Care Privacy.Roger S. Magnusson - 2004 - Journal of Law, Medicine and Ethics 32 (4):680-691.

Add more citations

Similar books and articles

Pharmacogenomics, Ethics, and Public Policy.Karen Peterson-Iyer - 2008 - Kennedy Institute of Ethics Journal 18 (1):pp. 35-56.
The Troubling Persistence of Race in Pharmacogenomics.Jonathan Kahn - 2012 - Journal of Law, Medicine and Ethics 40 (4):873-885.
Pharmacogenomics: Social, Ethical, and Clinical Dimensions.A. Hedgecoe - 2004 - Journal of Medical Ethics 30 (6):e6-e6.
Race, Pharmacogenomics, and Marketing: Putting BiDil in Context.Jonathan Kahn - 2006 - American Journal of Bioethics 6 (5):W1-W5.
Ontological Issues in Pharmacogenomics.Russ B. Altman - 2007 - The Monist 90 (4):523-533.
Some Causal Limitations of Pharmacogenetic Concepts.David Badcott - 2006 - Medicine, Health Care and Philosophy 9 (3):307-316.
Human Genetic Testing Under Examination by the European Union.Raymond E. Spier - 2004 - Science and Engineering Ethics 10 (3):579-586.
Clinical and Moral Challenges of Pharmacogenomics.Amalia M. Issa - 2001 - The National Catholic Bioethics Quarterly 1 (4):541-553.
Decisions on Pharmacogenomic Tests in the USA and Germany.Odette Wegwarth, Robert W. Day & Gerd Gigerenzer - 2011 - Journal of Evaluation in Clinical Practice 17 (2):228-235.


Added to PP index

Total views
14 ( #728,462 of 2,498,172 )

Recent downloads (6 months)
2 ( #282,957 of 2,498,172 )

How can I increase my downloads?


My notes